Without leading edge innovations and coordination, Canadians will die from the epidemic of antibiotic resistant infections.
Academic rigour, journalistic flair
Articles on Pharmaceutical industry
Displaying 41 - 54 of 54 articles
Drug companies funded more than 116,000 educational events for doctors over four years. Now you can find out exactly which companies footed the bills and how much they paid.
Globalised drug manufacturing is adding to the problem of antimicrobial resistance.
A push towards prescribing generic medications rather than their branded equivalents, as flagged in the budget, may have benefits beyond simple cost savings.
Australia is spending more than A$500 million a year too much for pharmaceuticals because of a little known loophole that allows drug companies to overcharge the government.
Firms with a focus on the domestic and regional market have an incentive to distribute their medicines effectively. Local production can create a win-win situation for health and employment.
Science and technology research has become so complicated and expensive that a gap has grown between the experiments scientists would like to do and what they have the means to do.
Decades have passed and yet the issue of financial compensation for the remaining “survivors” of the thalidomide tragedy has, in many instances, remained unresolved.
Thalidomide’s manufacturer, Chemie Grünenthal, marketed the drug as safe for pregnant women despite reports it was causing malformations in newborns. Why such blatant denial?
Pharmaceutical companies can use prescription medication ads to mislead an unwitting public for the sake of profits. While Australia prohibits such ads, the laws don’t go far enough.
Africa’s pharmaceutical industry has mushroomed in the last ten years. But its ability to keep pace with demand is being held back by a number of factors, including a shortage of specialists.
We need new ways to pay drug producers if we are to make treatments available where they’re really needed.
The 2015 Nobel Prize in medicine went to research on remedies derived from natural compounds. Academia is continuing the fight against ‘neglected’ diseases by similarly hunting for new drugs in nature.
African traditional medicine is widely relied on in South Africa but better understanding of its effects are needed for it to be accepted..
Top contributors
-
Joel Lexchin is a Friend of The Conversation.Professor Emeritus of Health Policy and Management, York University, Canada
-
Assistant Professor, Bond University
-
Associate professor, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Professor, School of Population and Public Health, University of British Columbia
-
Lecturer in Criminology, University of Auckland, Waipapa Taumata Rau
-
Reader in Intellectual Property Law, City, University of London
-
Adjunct Professor, Australian Centre for Health Law Research, School of Law, Queensland University of Technology
-
Associate Professor: Medicinal plant biotechnology, Stellenbosch University
-
Professor and Distinguished Research Chair, Globalization and Health Equity, L’Université d’Ottawa/University of Ottawa
-
Assistant Professor, Sociology, University of Victoria
-
Research Fellow, Flinders University
-
Research fellow, Centre for Health Economics, University of York
-
Professor, Centre for Health Economics, University of York
-
Associate Professor of Chemistry, Northeastern University
-
Associate Professor in the SAMRC Centre for Health Economics and Decision Science - PRICELESS SA (Priority Cost Effective Lessons in Systems Strengthening South Africa), University of the Witwatersrand
